Recurrent Colon Adenocarcinoma
1 clinical trials · Condition
◉ Watch Recurrent Colon Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study (NCT04109924) | Roswell Park Cancer Institute | 2019-12-27 |
Track Recurrent Colon Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.